SCHEMBL26535753

SCHEMBL26535753

c1cc(-c2cccc(-c3cc4ccccc4s3)c2)cc(-c2ccc3c4ccccc4c4ccccc4c3c2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 1/20 0.65
▸ HSD17B2 P37059 1/20 0.65
▸ APP P05067 2/20 0.58
▸ CA1 P00915 1/20 0.51
▸ CA2 P00918 1/20 0.51
▸ CA9 Q16790 1/20 0.51
▸ ERN1 O75460 2/20 0.48
▸ ESR1 P03372 3/20 0.45
▸ ESR2 Q92731 3/20 0.45
▸ CYP1A1 P04798 3/20 0.44
▸ CYP1B1 Q16678 3/20 0.44
▸ NQO1 P15559 1/20 0.44
▸ NQO2 P16083 1/20 0.44
▸ NPC1 O15118 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13129267 0.93 APP (0.61) HSD17B1HSD17B2APPCA1CA2
SCHEMBL13616015 0.86 HSD17B1 (0.52) HSD17B1HSD17B2APPCA1CA2
SCHEMBL27631114 0.86 HSD17B1 (0.77) HSD17B1HSD17B2APPCA1CA2
SCHEMBL24368513 0.86 APP (0.50) HSD17B1HSD17B2APPCA1CA2
SCHEMBL16437977 0.86 APP (0.50) HSD17B1HSD17B2APPCA1CA2
SCHEMBL13615832 0.85 APP (0.56) HSD17B1HSD17B2APPCA1CA2
SCHEMBL12405266 0.85 APP (0.59) HSD17B1HSD17B2APPCA1CA2
SCHEMBL13615886 0.85 APP (0.59) HSD17B1HSD17B2APPCA1CA2
SCHEMBL30340807 0.84 HSD17B1 (0.75) HSD17B1HSD17B2APPCA1CA2
SCHEMBL21014379 0.84 HSD17B1 (0.61) HSD17B1HSD17B2APPCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322691-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2023-10-12 — — US disclosed
US-20230322691-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2023-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322691-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CCNT1, CCNE2, SCO2 HSD17B1 2341/4885HSD17B2 2125/4885APP 845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback